Skin Microbiome Dynamics in Atopic Dermatitis: Understanding Host-Microbiome Interactions.

Area of Science:

• Dermatology
• Microbiology
• Immunology

Background:

• Atopic dermatitis (AD) is a chronic inflammatory skin disorder with compromised skin barrier function.
• Skin microbiome dysbiosis, characterized by reduced diversity and Staphylococcus aureus overgrowth, is a hallmark of AD.
• Staphylococcus aureus exacerbates skin barrier dysfunction and immune dysregulation in AD patients.

Purpose of the Study:

• To review recent advances in understanding the relationship between microbial metabolites and AD pathogenesis.
• To examine the therapeutic potential of microbiome-targeted interventions for AD.
• To explore future therapeutic strategies focusing on commensal-derived metabolites.

Main Methods:

• Literature review of recent advances in AD research.
• Analysis of the role of microbial metabolites in AD pathophysiology.
• Evaluation of microbiome-targeted interventions for AD treatment.

Main Results:

• Microbial metabolites significantly influence cutaneous immune responses, lipid metabolism, and skin barrier integrity in AD.
• Altered metabolite profiles, including reduced beneficial metabolites, correlate with AD severity.
• Staphylococcus aureus overabundance is linked to disrupted lipid metabolism, worsening skin barrier function.

Conclusions:

• Restoring skin microbial diversity and rebalancing metabolite production are key therapeutic goals for AD.
• Microbiome-targeted interventions like probiotics and prebiotics offer potential for improving AD clinical outcomes.
• Targeting commensal-derived metabolites presents a promising future therapeutic avenue for AD symptom management and disease modulation.